Talcum Powder Litigation Report
Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
SEARCH THE ARCHIVES
Issue #36, November 2019
A New York trial court has rejected challenges to forum in an asbestos-containing talcum powder action brought by a Texas woman, saying that the defendant’s ties to New York are enough to prevent dismissal on forum non conveniens grounds.
The Special Master appointed to oversee discovery disputes in the national talcum powder multidistrict litigation docket has weighed in on the dispute relating to the recall of a single lot of Johnson & Johnson’s Baby Powder, outlining testing procedures to be followed in the wake of the announcement.
The FDA has made public the Certificate of Analysis and supporting documentation for the Johnson & Johnson’s Baby Powder sample that tested positive for chrysotile asbestos, according to a recent letter sent to the federal judge overseeing the talcum powder multidistrict litigation docket.
The national talcum powder multidistrict litigation Plaintiffs’ Steering Committee has written another letter to the MDL Judge in regard to the recent recall of a single lot of Baby Powder, saying that Johnson & Johnson made “several inaccurate statements” in its letter to the court.
Issue #35, October 2019
Johnson & Johnson: Baby Powder Recall ‘Doesn’t Move Needle on Whether Plaintiffs Have Scientific Evidence of Causation’
Johnson & Johnson has responded to a letter written by the Plaintiffs’ Steering Committee to the national multidistrict litigation docket for talcum powder claims regarding the defendant’s recent recall of a single lot of Baby Powder, “strongly objecting” the PSC’s suggestion that the recall merits the reopening of the Daubert hearing record.
Talcum Powder Plaintiff Steering Committee Seeks More Information on Baby Powder Recall, Wants to Supplement Daubert Brief
The Plaintiffs’ Steering Committee has sent a letter to the federal court overseeing the national multidistrict litigation docket for talcum powder claims, alerting the MDL judge to Johnson & Johnson’s recent recall of a single lot of baby powder as a result of positive asbestos testing.
Johnson & Johnson Consumer Inc. Recalls Single Lot of Baby Powder After Tests Reveal Presence of Asbestos
Johnson & Johnson Consumer Inc. announced in a press release that it has voluntarily recalled a single lot of Baby Powder after tests indicated the presence of “sub-trace” levels of chrysotile asbestos.
Missouri Appellate Court Says Talc Ovarian Cancer Appeal Properly Before Court, Reverses $110 Million Verdict
A Missouri appellate court has reversed a $110 million talcum powder ovarian cancer verdict, again finding that the trial court lacked personal jurisdiction over the plaintiffs under the U.S. Supreme Court’s Bristol-Myers Squibb decision.
A plaintiff with talcum powder ovarian cancer claims pending in Florida state court has opposed several motions to dismiss for lack of jurisdiction, maintaining that the defendants bottled talc products for Johnson & Johnson and those products were sold in the state of Florida.
Fla. State Court Denies GSK’s Motion to Dismiss Asbestos Cosmetic Talc Case for Lack of Jurisdiction
A Florida state court has denied GlaxoSmithKline’s efforts to throw out asbestos cosmetic talcum powder claims, rejecting the defendant’s stance that the court did not have personal jurisdiction over the claims.